{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:10:18Z","timestamp":1790367018553,"version":"4.1.0"},"reference-count":15,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Estimates of the risk of recurrent cardiovascular events (residual risk) among patients with acute coronary syndromes have largely been based on clinical trial populations. Our objective was to estimate the residual risk associated with common comorbidities in a large, unselected, population-based cohort of acute coronary syndrome patients. 31,056 ACS patients (49.5%\u2014non-ST segment elevation myocardial infarction [NSTEMI], 34.0%\u2014ST segment elevation myocardial infarction [STEMI] and 16.5%\u2014unstable angina [UA]) hospitalised in Alberta between April 2010 and March 2016 were included. The primary composite outcome was major adverse cardiovascular events (MACE) including: death, stroke or recurrent myocardial infarction. The secondary outcome was death from any cause. Cox-proportional hazard models were used to identify the impact of ACS type and commonly observed comorbidities (heart failure, hypertension, peripheral vascular disease, renal disease, cerebrovascular disease and diabetes). At 3.0 +\/- 3.7 years, rates of MACE were highest in the NSTEMI population followed by STEMI and UA (3.58, 2.41 and 1.68 per 10,000 person years respectively). Mortality was also highest in the NSTEMI population followed by STEMI and UA (2.23, 1.38 and 0.95 per 10,000 person years respectively). Increased burden of comorbidities was associated with an increased risk of MACE, most prominently seen with heart failure (adjusted HR 1.83; 95% CI 1.73\u20131.93), renal disease (adjusted HR 1.52; 95% CI 1.40\u20131.65) and diabetes (adjusted HR 1.51; 95% CI 1.44\u20131.59). The cumulative presence of each of examined comorbidities was associated with an incremental increase in the rate of MACE ranging from 1.7 to 9.98 per 10,000 person years. Rates of secondary prevention medications at discharge were high including: statin (89.5%), angiotensin converting enzyme inhibitor\/angiotensin receptor blocker (84.1%) and beta-blockers (85.9%). Residual cardiovascular risk following an acute coronary syndrome remains high despite advances in secondary prevention. A higher burden of comorbidities is associated with increased residual risk that may benefit from aggressive or novel therapies.<\/jats:p>","DOI":"10.1371\/journal.pone.0254008","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T14:18:45Z","timestamp":1625149125000},"page":"e0254008","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":44,"title":["Long-term risk of death and recurrent cardiovascular events following acute coronary syndromes"],"prefix":"10.1371","volume":"16","author":[{"given":"Pishoy","family":"Gouda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anamaria","family":"Savu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin R.","family":"Bainey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padma","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2613-9142","authenticated-orcid":true,"given":"Robert C.","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"key":"pone.0254008.ref001","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2018.11.138","article-title":"The FAST-MI 2005-2010-2015 registries in the light of the COMPASS trial: The COMPASS criteria applied to a post-MI population","volume":"278","author":"F Schiele","year":"2019","journal-title":"International journal of cardiology"},{"issue":"1","key":"pone.0254008.ref002","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.amjmed.2010.07.023","article-title":"Recent Trends in the Incidence, Treatment, and Outcomes of Patients with STEMI and NSTEMI","volume":"124","author":"DD McManus","year":"2011","journal-title":"The American Journal of Medicine"},{"issue":"10","key":"pone.0254008.ref003","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/jama.2016.10766","article-title":"Association of Clinical Factors and Therapeutic Strategies With Improvements in Survival Following Non\u2013ST-Elevation Myocardial Infarction, 2003\u20132013","volume":"316","author":"M Hall","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"pone.0254008.ref004","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/jamacardio.2019.0179","article-title":"Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial","volume":"4","author":"P Mani","year":"2019","journal-title":"JAMA Cardiology"},{"issue":"12","key":"pone.0254008.ref005","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.118.034311","article-title":"Lipoprotein (a) levels and the risk of myocardial infarction among 7 ethnic groups","volume":"139","author":"G Par\u00e9","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"pone.0254008.ref006","first-page":"1","article-title":"Residual risk factors to predict major adverse cardiovascular events in atherosclerotic cardiovascular disease patients with and without diabetes mellitus","volume":"7","author":"F-J Lin","year":"2017","journal-title":"Scientific reports"},{"issue":"1","key":"pone.0254008.ref007","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/jhh.2009.34","article-title":"Residual cardiovascular risk in treated hypertension and hyperlipidaemia: the PRIME Study","volume":"24","author":"J Blacher","year":"2010","journal-title":"Journal of Human Hypertension"},{"issue":"1","key":"pone.0254008.ref008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2007.02.046","article-title":"Impact of Prior Peripheral Arterial Disease and Stroke on Outcomes of Acute Coronary Syndromes and Effect of Evidence-Based Therapies (from the Global Registry of Acute Coronary Events)","volume":"100","author":"D Mukherjee","year":"2007","journal-title":"The American Journal of Cardiology"},{"issue":"5","key":"pone.0254008.ref009","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.arcmed.2015.05.009","article-title":"Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein","volume":"46","author":"V Kon","year":"2015","journal-title":"Archives of Medical Research"},{"issue":"11","key":"pone.0254008.ref010","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.amjcard.2020.02.044","article-title":"Temporal Trends in Comorbidity Burden and Impact on Prognosis in Patients With Acute Coronary Syndrome Using the Elixhauser Comorbidity Index Score","volume":"125","author":"F Zhang","year":"2020","journal-title":"The American Journal of Cardiology"},{"issue":"6","key":"pone.0254008.ref011","first-page":"571","article-title":"Outcomes of medically managed patients with myocardial infarction","volume":"8","author":"P Kaul","year":"2019","journal-title":"European Heart Journal: Acute Cardiovascular Care"},{"issue":"10","key":"pone.0254008.ref012","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.amjcard.2010.06.070","article-title":"Comparison of Baseline Characteristics, Management and Outcome of Patients With Non\u2013ST-Segment Elevation Acute Coronary Syndrome in Versus Not in Clinical Trials","volume":"106","author":"AB Hutchinson-Jaffe","year":"2010","journal-title":"The American Journal of Cardiology"},{"issue":"1","key":"pone.0254008.ref013","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12872-017-0482-9","article-title":"Mortality and morbidity trends after the first year in survivors of acute myocardial infarction: a systematic review","volume":"17","author":"S Johansson","year":"2017","journal-title":"BMC Cardiovascular Disorders"},{"issue":"11","key":"pone.0254008.ref014","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/clc.22583","article-title":"Residual Ischemic Risk and Its Determinants in Patients With Previous Myocardial Infarction and Without Prior Stroke or TIA: Insights From the REACH Registry","volume":"39","author":"J Abtan","year":"2016","journal-title":"Clinical Cardiology"},{"issue":"9","key":"pone.0254008.ref015","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S1885-5857(06)60649-X","article-title":"Prognostic Value of Charlson Comorbidity Index at 30 Days and 1 Year After Acute Myocardial Infarction","volume":"57","author":"JE N\u00fa\u00f1ez","year":"2004","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0254008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T14:19:03Z","timestamp":1625149143000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0254008"}},"subtitle":[],"editor":[{"given":"Yoshihiro","family":"Fukumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":15,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0254008","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]}}}